Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01582295
Title XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

multiple myeloma

Therapies

Cabozantinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.